Lateral Flow Device (LFD) service launches
The service, which is funded outside of the CPCF global sum, will allow eligible patients who have risk factors for progression to severe COVID-19 to obtain LFD test kits from participating community pharmacies.
Access to LFD test kits allows eligible patients to self-test if they have symptoms which suggest they may have COVID-19, with the potential for them to access treatment if the result is positive.
A service fee of £4 + VAT will be paid for each completed transaction of the supply of one box of five COVID-19 LFD test kits and the cost of tests supplied will be paid according to arrangements set out in the November 2023 Drug Tariff.
When ready to provide the service, pharmacy owners will be able to sign up on the NHSBSA’s MYS portal from 6th November 2023, after which they will be able to provide the service.